CV_Logo_Horizontal_black_300dpi (1).png
CV Sciences, Inc. CEO Issues Letter to Shareholders
12 août 2019 08h45 HE | CV Sciences, Inc.
SAN DIEGO, Aug. 12, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
CV_Logo_Horizontal_black_300dpi (1).png
CV Sciences, Inc. Reports Second Quarter 2019 Financial Results
06 août 2019 16h00 HE | CV Sciences, Inc.
Record quarterly revenue Increased retail distribution by over 1,200 stores SAN DIEGO, Aug. 06, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) ("CV Sciences" or the “Company”) announced...
CV_Logo_Horizontal_black_300dpi (1).png
CV Sciences, Inc. Announces Expanded Distribution Partnership With The Kroger Co.
30 juil. 2019 15h05 HE | CV Sciences, Inc.
PlusCBD™ Oil Topicals Now Available at 1,350 Kroger Stores SAN DIEGO, July 30, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a...
CV_Logo_Horizontal_black_300dpi (1).png
CV Sciences, Inc. Applauds Ohio’s State Law Passage of Senate Bill 57
30 juil. 2019 12h49 HE | CV Sciences, Inc.
Senate Bill 57 Legalizes Hemp Cultivation and CBD Sales in Ohio SAN DIEGO, July 30, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a...
CV_Logo_Horizontal_black_300dpi (1).png
CV Sciences, Inc. to Announce Second Quarter 2019 Results on August 6, 2019
23 juil. 2019 08h45 HE | CV Sciences, Inc.
SAN DIEGO, July 23, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”) announced that it will release financial results for its second...
CV_Logo_Horizontal_black_300dpi (1).png
CV Sciences, Inc. Expands Operations with New Production and Warehousing Facility to Support Worldwide Growth Opportunities
16 juil. 2019 08h45 HE | CV Sciences, Inc.
Facility Expansion Increases Hemp CBD Oil Production and Warehousing/Fulfillment Capacity by More Than 500 Percent SAN DIEGO, July 16, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the...
CV_Logo_Horizontal_black_300dpi (1).png
CV Sciences, Inc. Announces Commitment to More Than 500 Acres of U.S. Hemp Production for 2019
10 juil. 2019 10h14 HE | CV Sciences, Inc.
Hemp CBD Pioneer Ramps Up Domestic Supply to Meet Growing Retailer and Consumer Demand SAN DIEGO, July 10, 2019 (GLOBE NEWSWIRE) --  CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”,...
CV_Logo_Horizontal_black_300dpi (1).png
Seminal Clinical Trial in Healthy Adults Demonstrates Promising Preliminary Evidence of PlusCBD™ Oil in Sleep, Wellness, and Weight-Loss Applications
17 juin 2019 13h05 HE | CV Sciences, Inc.
First-Ever Double-Blind, Randomized Study Titled, “Effects of a CBD-containing Supercritical Fluid Extract of Hemp on Markers of Optimal Wellness, Stress Resilience, and Recovery in Healthy Subjects,”...
CV_Logo_Horizontal_black_300dpi (1).png
Groundbreaking Research Proves Efficacy of PlusCBD™ Oil in Sleep, Wellness and Weight-Loss Applications
17 juin 2019 08h45 HE | CV Sciences, Inc.
First-Ever Double-Blind, Randomized Study Titled, “Effects of a CBD-containing Supercritical Fluid Extract of Hemp on Markers of Optimal Wellness, Stress Resilience, and Recovery in Healthy Subjects,”...
CV_Logo_Horizontal_black_300dpi (1).png
CV Sciences, Inc. to Present at the Oppenheimer 19th Annual Consumer Conference
13 juin 2019 08h45 HE | CV Sciences, Inc.
LAS VEGAS, June 13, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”) a preeminent supplier and manufacturer of hemp CBD products through...